Innova Captab Ltd

NSE
INNOVACAP •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Innova Captab Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Dec 29, 2023
18.9
TTM PE Ratio
Below industry Median
49.2
Price to Book Ratio
High in industry
11.4
Dividend yield 1yr %
0
TTM PEG Ratio
RSI
RSI is mid-range
49.9
MFI
MFI is mid-range
52.1

Innova Captab Ltd Key Financials

*All values are in ₹ Cr.

Innova Captab Ltd shareholding Pattern

Promoter
50.9%
Foreign Institutions
3.6%
Mutual Funds
3.4%
Domestic Institutions
11.7%
Public
33.8%

Innova Captab Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
5
5Day EMA
533.50
10Day EMA
533.00
12Day EMA
532.90
20Day EMA
532.30
26Day EMA
531.90
EMA
NaN
EMA
NaN
EMA
NaN
Delivery & Volume
Resistance & Support
531.95
Pivot
Resistance
First Resistance
536.80
Second Resistance
540.85
Third Resistance
545.70
Support
First Support
527.90
Second support
523.05
Third Support
519
Relative Strength Index
49.89
Money Flow Index
52.10
MACD
0.84
MACD Signal
0.62
Average True Range
20.08
Average Directional Index
24.57
Rate of Change (21)
2.06
Rate of Change (125)
0.00

Innova Captab Ltd Company background

Founded in: 2005
Managing director: VINAY KUMAR LOHARIWALA
Innova Captab Ltd was incorporated as Harun Health Care Private Limited, dated January 3, 2005 at Mumbai. Thereafter, name of the Company changed from Harun Health Care Private Limited to Innova Captab Private Limited, and consequently, a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company. Subsequently, Company converted to a Public Company on July 12, 2018, and consequently, its name was changed to Innova Captab Limited, dated July 26, 2018.The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business. Their CDMO product portfolio spans across both acute and chronic therapeutic areas. These CDMO services and products include commercial largescale manufacturing of generic products, which allow customers in offering multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, modified and release forms of tablets in capsules. It has 2 manufacturing facilities in Baddi, Himachal Pradesh. Their facilities further produce tablets, capsules, dry syrups, dry powder injections, ointments and liquid orals. In 2006, the first manufacturing plant got established in Baddi, at Himachal Pradesh. In 2010, it commenced operations at the cephalosporin block of their plant in Baddi. In 2021, the Company acquired business of Innova Captab, a Partnership Firm effective as of March 31, 2021 and acquired Univentis Medicare Limited (UML) 100% equity shares effective on December 31, 2021 and consequently, The Univentis Foundation became a Subsidiary of Company on June 14, 2021.The Company is planning to raise capital from Public by raising 400 crore Equity Shares through Fresh Issue and 9,600,000 Equity Shares through Offer for Sale.
Read More

Innova Captab Ltd FAQs

Innova Captab Ltd shares are currently priced at 532.75 on NSE and 531.85 on BSE as of 2/29/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Innova Captab Ltd [INNOVACAP] share was 0. The Innova Captab Ltd [INNOVACAP] share hit a 1-year low of Rs. 452.1 and a 1-year high of Rs. 588.

The market cap of Innova Captab Ltd is Rs. 3048.66 Cr. as of 2/29/2024 12:00:00 AM.

The PE ratios of Innova Captab Ltd is 49.15 as of 2/29/2024 12:00:00 AM.

The PB ratios of Innova Captab Ltd is 4.68 as of 2/29/2024 12:00:00 AM

The Mutual Fund Shareholding was 3.4% at the end of 2/29/2024 12:00:00 AM.

You can easily buy Innova Captab Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage